Free Trial

Natural Investments LLC Grows Position in Procter & Gamble Company (The) $PG

Procter & Gamble logo with Consumer Staples background

Key Points

  • Natural Investments LLC increased its holdings in Procter & Gamble by 32.9%, now owning 16,936 shares valued at $2,698,000 as of the latest filing.
  • Procter & Gamble reported $20.89 billion in revenue for the last quarter, exceeding analyst expectations, with an earnings per share (EPS) of $1.48.
  • The stock currently has an average rating of "Moderate Buy" from analysts, with a consensus target price of $172.21.
  • Five stocks we like better than Procter & Gamble.

Natural Investments LLC lifted its holdings in shares of Procter & Gamble Company (The) (NYSE:PG - Free Report) by 32.9% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 16,936 shares of the company's stock after purchasing an additional 4,191 shares during the quarter. Natural Investments LLC's holdings in Procter & Gamble were worth $2,698,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds have also modified their holdings of PG. Kingstone Capital Partners Texas LLC grew its holdings in shares of Procter & Gamble by 655,209.0% during the 2nd quarter. Kingstone Capital Partners Texas LLC now owns 76,028,952 shares of the company's stock worth $11,832,680,000 after purchasing an additional 76,017,350 shares during the period. Nuveen LLC purchased a new position in shares of Procter & Gamble during the 1st quarter worth $1,954,941,000. Price T Rowe Associates Inc. MD grew its holdings in shares of Procter & Gamble by 13.0% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 21,480,670 shares of the company's stock worth $3,660,737,000 after purchasing an additional 2,466,308 shares during the period. Invesco Ltd. grew its holdings in shares of Procter & Gamble by 19.8% during the 1st quarter. Invesco Ltd. now owns 13,493,604 shares of the company's stock worth $2,299,580,000 after purchasing an additional 2,228,151 shares during the period. Finally, Valeo Financial Advisors LLC grew its holdings in shares of Procter & Gamble by 1,875.5% during the 2nd quarter. Valeo Financial Advisors LLC now owns 1,763,404 shares of the company's stock worth $280,946,000 after purchasing an additional 1,674,139 shares during the period. 65.77% of the stock is currently owned by hedge funds and other institutional investors.

Procter & Gamble Price Performance

PG stock opened at $149.69 on Friday. The company has a debt-to-equity ratio of 0.49, a current ratio of 0.70 and a quick ratio of 0.49. The firm has a market capitalization of $350.34 billion, a P/E ratio of 22.99, a P/E/G ratio of 3.97 and a beta of 0.36. The business's 50-day moving average is $155.24 and its two-hundred day moving average is $159.48. Procter & Gamble Company has a 1 year low of $149.45 and a 1 year high of $180.43.

Procter & Gamble (NYSE:PG - Get Free Report) last posted its quarterly earnings results on Tuesday, July 29th. The company reported $1.48 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.42 by $0.06. The company had revenue of $20.89 billion for the quarter, compared to analyst estimates of $20.79 billion. Procter & Gamble had a return on equity of 32.69% and a net margin of 18.95%.Procter & Gamble's revenue for the quarter was up 1.7% compared to the same quarter last year. During the same quarter last year, the company earned $1.40 EPS. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. Analysts anticipate that Procter & Gamble Company will post 6.91 earnings per share for the current fiscal year.

Insider Buying and Selling at Procter & Gamble

In other news, CEO Jennifer L. Davis sold 3,227 shares of the firm's stock in a transaction dated Thursday, October 2nd. The stock was sold at an average price of $152.23, for a total transaction of $491,246.21. Following the sale, the chief executive officer owned 61,764 shares of the company's stock, valued at approximately $9,402,333.72. This trade represents a 4.97% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Jon R. Moeller sold 11,684 shares of the firm's stock in a transaction dated Thursday, October 2nd. The stock was sold at an average price of $152.23, for a total value of $1,778,655.32. Following the sale, the chief executive officer directly owned 319,932 shares in the company, valued at $48,703,248.36. This trade represents a 3.52% decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 149,763 shares of company stock worth $23,421,279. 0.20% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

Several equities analysts recently issued reports on PG shares. Evercore ISI reissued an "in-line" rating and set a $170.00 target price (down previously from $190.00) on shares of Procter & Gamble in a research note on Monday, July 14th. Berenberg Bank increased their target price on Procter & Gamble from $152.00 to $154.00 and gave the stock a "hold" rating in a research note on Wednesday, September 17th. BNP Paribas reissued an "outperform" rating and set a $177.00 target price on shares of Procter & Gamble in a research note on Friday, August 15th. Barclays decreased their target price on Procter & Gamble from $164.00 to $153.00 and set an "equal weight" rating on the stock in a research note on Wednesday, October 1st. Finally, Wells Fargo & Company decreased their target price on Procter & Gamble from $173.00 to $170.00 and set an "overweight" rating on the stock in a research note on Thursday, September 25th. Eleven analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company's stock. According to data from MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus target price of $172.21.

View Our Latest Stock Analysis on Procter & Gamble

Procter & Gamble Company Profile

(Free Report)

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.

Further Reading

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Procter & Gamble Right Now?

Before you consider Procter & Gamble, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.

While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report
Like this article? Share it with a colleague.